Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory B Cell Lymphoma

Name: Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory B Cell Lymphoma
License: Public Domain

Shanxi Province Cancer Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

lymphoma, b-cell

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 451461
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.